NATCOPHARM.BONATCOPHARM.BOBSE
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank21
3Y CAGR-27.0%
5Y CAGR-10.7%
Year-over-Year Change
Enterprise value to sales ratio
3Y CAGR
-27.0%/yr
vs +3.4%/yr prior
5Y CAGR
-10.7%/yr
Recent deceleration
Acceleration
-30.3pp
Decelerating
Percentile
P21
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
1 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 2.83 | -36.5% |
| 2024 | 4.45 | +16.6% |
| 2023 | 3.81 | -47.4% |
| 2022 | 7.25 | -2.7% |
| 2021 | 7.45 | +49.7% |
| 2020 | 4.98 | -3.5% |
| 2019 | 5.16 | -18.8% |
| 2018 | 6.35 | -14.5% |
| 2017 | 7.43 | +7.2% |
| 2016 | 6.93 | - |